Riskpilot← Back to searchSign inGet full accessDr Egen AB
ABActiveOrg 5567237036Södermannagatan 44Literary creation and musical composition activities · NACE 9011Est. 20071 employees
Revenue 2024
SEK 1,5M
-13% vs 2023
EBITDA margin
17.7%
-16% vs 2023
Equity ratio
93.3%
Financial strength
Net profit 2024
SEK 326K
-2% vs 2023
| Revenue | SEK 1,5M | -13% |
| EBITDA | SEK 273K | -16% |
| Net profit | SEK 326K | -2% |
| Total assets | SEK 5,1M | -3% |
| Equity | SEK 4,7M | +3% |
| Employees | 1 | — |
Legal name
Dr Egen AB
Org number
5567237036
Legal form
Aktiebolag
NACE code
9011 · Literary creation and musical composition activities
Founded
14 februari 2007
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva PR, reklam, marknadsföring, produktion av musik, lyrik och litteratur, konsultation inom ljud, bild, text, artist-, produktions- och mediaverksamhet samt därmed förenlig verksamhet.
Address
Södermannagatan 44
Phone
+46735313666
Email
dregen@dregen.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 001 | 629 | 4 101 | 1 772 | 1 549 |
| Staff expenses | — | — | −1 074 | −796 | −480 |
| EBITDA | 56 | 44 | 1 618 | 327 | 273 |
| Depreciation & amort. | −13 | −13 | −7 | −5 | — |
| EBIT | 43 | 31 | 1 610 | 321 | 273 |
| Net financials | — | 144 | 5 | 108 | 143 |
| Profit before tax | 43 | 175 | 1 615 | 429 | 417 |
| Tax | −15 | −42 | −345 | −98 | −91 |
| Net profit | 28 | 133 | 1 270 | 331 | 326 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 864 | 4 007 | 5 875 | 5 222 | 5 058 |
| Equity | 3 308 | 3 440 | 4 711 | 4 591 | 4 717 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 557 | 567 | 1 165 | 631 | 341 |
| Total debt | 557 | 567 | 1 165 | 631 | 341 |
EBITDA margin
17.7%
This company
15.8%
Market median
+12% vs market
20202024
Equity ratio
93.3%
This company
38.2%
Market median
+144% vs market
20202024
Return on equity
6.9%
This company
18.4%
Market median
-63% vs market
20202024
Net profit margin
21.0%
This company
8.1%
Market median
+159% vs market
20202024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20202024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Egen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mariann Svensson | Deputy Board Member | 0 companies |
| Andreas Tyrone Dregen | Board of Directors | 0 companies |